Images_Of_Money/Flickr Creative Commons

The main drug industry trade group is launching a massive ad campaign to highlight the medical advances that have been created in the last few years — a counterstrike against the attacks they're facing over rising drug prices.

The Pharmaceutical Research and Manufacturers of America is pushing out a series of TV, print, digital and social ads, and there will be a series of events around the country to talk about medical innovation.

Why now: The industry is under fire from President Trump and many Democrats for rising drug prices, and PhRMA's leaders are concerned that the value of recent medical advances is being lost. PhRMA president and CEO Steve Ubl blames scandals around drug companies like Turing, Valeant and Mylan for driving the conversation through recent price hikes. But they say the campaign has been in the works for six months, and would have looked the same regardless of who was elected president.

We don't have a discussion today that addresses the value of the products, and it's driven by three bad actors. — Steve Ubl, PhRMA president and CEO

What you'll see: The ads will feature recent advances like personalized medicine — which finds treatments that are most likely to work on a given patient — and immunotherapy, which boosts the body's immune system to help it fight cancer.

What they'll spend: PhRMA spokesman Robert Zirkelbach wouldn't give exact numbers, but said it will be in the "high tens of millions of dollars every year" over the next four to five years.

What they want: Ubl says the drug industry wants to push for changes like "modernizing the FDA" to encourage medical innovation more easily, as well as changing the payment system to pay for the drugs with the most value.

What they would say to Trump: "I'm optimistic that we're going to find common ground," Ubl said. Asked whether he wanted to comment on Trump's proposal to let Medicare negotiate drug prices: "I'd rather not."

Go deeper

Amy Harder, author of Generate
35 mins ago - Energy & Environment

Climate change goes mainstream in presidential debate

Photo illustration: Aïda Amer/Axios. Photo: Olivier Douliery-Pool/Getty

The most notable part of Thursday’s presidential debate on climate change was the fact it was included as a topic and assumed as a fact.

The big picture: This is the first time in U.S. presidential history that climate change was a featured issue at a debate. It signals how the problem has become part of the fabric of our society. More extreme weather, like the wildfires ravaging Colorado, is pushing the topic to the front-burner.

Finally, a real debate

Photo: Morry Gash/AP

A more disciplined President Trump held back from the rowdy interruptions at tonight's debate in Nashville, while making some assertions so outlandish that Joe Biden chuckled and even closed his eyes.

  • A Trump campaign adviser told Axios: "He finally listened." 

The result: A real debate.

Biden to Trump: "I have not taken a penny from any foreign source ever in my life"

Former VP Joe Biden pushed back Thursday against allegations from President Trump, saying he had never profited from foreign sources. "Nothing was unethical," Biden told debate moderator Kristen Welker about his son Hunter's work in Ukraine while he was vice president.

Why it matters: Earlier on Thursday, Hunter Biden's former business partner, Tony Bobulinski, released a statement saying Joe Biden's claims that he never discussed overseas business dealings with his son were "false."